InvestorsHub Logo
Followers 49
Posts 4582
Boards Moderated 0
Alias Born 09/01/2017

Re: DJPele post# 535280

Friday, 11/18/2022 11:19:30 PM

Friday, November 18, 2022 11:19:30 PM

Post# of 731889
Celgene was bought by BMY after Celgene had big revenues from Revlimid and early investors had something like 5000% returns already.

I bought Celgene stock fairly late and still made 2-3 times my investment (a much, much smaller investment than for nwbo) however nwbo is very different, being pre-revenue and about to apply for its first approval, no substantial corporate functional/staff structure, no marketing/sales, No PAC, etc.

So nwbo is more like Celgene in its infancy.

Imo nwbo has a much larger potential to grow into than Celgene in due time.

It’s also imo and self interests that me being decades older than when I bought Celgene, as are LP and LG, that making a fair deal with an entity that will be committed to make the most of the technology for humanity and not shelve it, is preferred for investors like me and cancer patients worldwide!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News